The contribution of the first two authors and the last two authors must be considered equal.
Exposure to Phosphodiesterase Type 5 Inhibitors Stimulates Aromatase Expression in Human Adipocytes in vitro
Article first published online: 22 DEC 2010
© 2010 International Society for Sexual Medicine
The Journal of Sexual Medicine
Volume 8, Issue 3, pages 696–704, March 2011
How to Cite
Aversa, A., Caprio, M., Antelmi, A., Armani, A., Brama, M., Greco, E. A., Francomano, D., Calanchini, M., Spera, G., Luigi, L. D., Rosano, G. M.C., Lenzi, A., Migliaccio, S. and Fabbri, A. (2011), Exposure to Phosphodiesterase Type 5 Inhibitors Stimulates Aromatase Expression in Human Adipocytes in vitro. Journal of Sexual Medicine, 8: 696–704. doi: 10.1111/j.1743-6109.2010.02152.x
- Issue published online: 24 FEB 2011
- Article first published online: 22 DEC 2010
- Nitric Oxide;
- Endothelial Health;
- PDE5 Inhibitors;
- Human Visceral Adipocytes
Introduction. Prolonged tadalafil administration in men with erectile dysfunction is associated with increased testosterone (T): estradiol (E2) ratio mainly related to reduction of E2 levels.
Aim. To investigate the presence of phosphodiesterase type 5 (PDE5) isoenzyme in primary human visceral adipocytes and whether different PDE5 inhibitors (PDE5i) could directly modulate aromatase (ARO) expression in differentiated human visceral adipocytes in culture.
Main Outcome Measures. PDE5 mRNA and protein expression in primary human visceral adipocytes as well as mRNA and protein expression of ARO, with functional activity after selective PDE5 blockade by tadalafil and sildenafil.
Methods. Purified primary human visceral pre-adipocytes were differentiated ex vivo and were exposed to tadalafil or sildenafil (1 µM) for different intervals of time (6-12-24-96 hours). ARO mRNA content and expression were measured by Western Blot and quantitative reverse transcription-polymerase chain reaction (qRT-PCR), respectively. T and E2 in supernatants were measured by ELISA also in the presence of letrozole.
Results. Differentiated adipocytes were found to express detectable levels of PDE5 transcripts. Acute exposure (6 hours) to both PDE5i tadalafil and sildenafil increased ARO mRNA expression by 4.7- and 2.8-fold, respectively (P < 0.001). ARO mRNA and protein levels were increased by the treatment with PDE5i in a time- and dose-dependent manner. Such effect was mimicked by 8-bromo-cGMP but was lost after 24 and 96 hours; differently, the PDE3B specific inhibitor milrinone (1 µM), displayed no effect. Accordingly, long-term exposure (24 and 96 hours) to PDE5i caused a significant increase in E2 concentrations in the supernatant (1.7 and 2 fold, respectively; P < 0.001), with a parallel reduction of T (15% and 30%, respectively; P < 0.001). Such effect was reversed by the co-incubation with the specific ARO-inhibitor letrozole.
Conclusions. Our results demonstrate that PDE5 is expressed in human visceral adipocytes and that acute exposure to PDE5i selectively stimulates ARO expression, which is related to a specific PDE5 blockade. We speculate that modulation of ARO activity by PDE5i could be one of the mechanisms responsible, at least in part, for the beneficial effects of PDE5i on endothelial and metabolic functions. Aversa A, Caprio M, Antelmi A, Armani A, Brama M, Greco EA, Francomano D, Calanchini M, Spera G, Luigi LD, Rosano GMC, Lenzi A, Migliaccio S, and Fabbri A. Exposure to phosphodiesterase type-5 inhibitors stimulates aromatase expression in human adipocytes in vitro. J Sex Med 2011;8:696–704.